PulseSelect™ PFA Global Registry

What this study is about

The PulseSelect™ PFA Global Registry is a prospective, global, multi-center, observational post-approval study. Subjects will be treated with the PulseSelect™ PFA System and followed according to SOC.

Who can join (things the study team will check)

✅ You may be able to join if…

• Subject is ≥ 18 years of age or minimum age as required by local regulations.
• Subject has been diagnosed with atrial fibrillation (AF)
• Planned procedure using commercially available PulseSelect™ PFA System.
• Willing to comply with study requirements and give informed consent (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this clinical study) or authorization per institution and geographical requirements.

🚫 You may not be able to join if…

• Subject is enrolled in a concurrent study that has not been approved for concurrent enrollment by the global study manager.
• Subject with exclusion criteria required by local law.

Where this trial is running

• Vancouver General Hospital, Vancouver, British Columbia, Canada
• McGill University Health Centre (MUHC), Montreal, Quebec, Canada
• Fuwai Hospital Chinese Academy of Medical Sciences, Beijing, China
• Fujian Provincial Hospital, Fuzhou, China
• The Second Affiliated Hospital of Harbin Medical University, Harbin, China
• Nanjing Drum Tower Hospital, Nanjing, China
• Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China
• Fuwai Shenzhen Hospital Chinese Academy of Medical Sciences, Shenzhen, China
• The First Affiliated Hospital of Xinjiang Medical University, Ürümqi, China
• Wuhan Asia General Hospital, Wuhan, China
• The First Affiliated Hospital of Xiamen University, Xiamen, China
• Klinička Bolnica Dubrava, Zagreb, Croatia

+ 25 more sites.

Who to contact

Josman Suri · 7635050262 · josman.suri@medtronic.com

It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT06393920.